Compare MEC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEC | TNDM |
|---|---|---|
| Founded | 1945 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.7M | 1.0B |
| IPO Year | 2019 | 2013 |
| Metric | MEC | TNDM |
|---|---|---|
| Price | $33.90 | $15.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 19 |
| Target Price | $24.33 | ★ $28.00 |
| AVG Volume (30 Days) | 593.6K | ★ 2.2M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $10.65 | $8.11 |
| Revenue Next Year | $8.66 | $11.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $12.10 | $10.00 |
| 52 Week High | $38.76 | $29.65 |
| Indicator | MEC | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 44.99 |
| Support Level | $33.06 | $13.59 |
| Resistance Level | $36.50 | $15.75 |
| Average True Range (ATR) | 1.89 | 0.91 |
| MACD | -0.40 | -0.00 |
| Stochastic Oscillator | 9.55 | 42.09 |
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.